telmisartan has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, T; Ou, Z; Tong, Q; Wu, L; Zhang, Y; Zhu, D | 1 |
1 other study(ies) available for telmisartan and Parkinson Disease
| Article | Year |
|---|---|
Inhibition of endoplasmic reticulum stress-activated IRE1α-TRAF2-caspase-12 apoptotic pathway is involved in the neuroprotective effects of telmisartan in the rotenone rat model of Parkinson's disease.
Topics: Animals; Apoptosis; Benzimidazoles; Benzoates; Caspase 12; Catalepsy; Disease Models, Animal; Dopamine; Endoplasmic Reticulum Stress; Endoribonucleases; Enzyme Activation; Male; Multienzyme Complexes; Neostriatum; Neuroprotective Agents; Parkinson Disease; Pars Compacta; PPAR delta; PPAR-beta; Protein Serine-Threonine Kinases; Rats; Rotenone; Signal Transduction; Telmisartan; TNF Receptor-Associated Factor 2 | 2016 |